Macular Degeneration: all 1,489 studies
Page 5 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)CompletedNCT01397409Phase 2Results posted
- Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular DegenerationTerminatedNCT01367444Phase 1/2Results posted
- 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)TerminatedNCT01362348Phase 2Results posted
- Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular DegenerationCompletedNCT01342926Phase 2Results posted
- ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) PatientsCompletedNCT01304693Phase 1/2Results posted
- Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)CompletedNCT01272076Results posted
- Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular DegenerationCompletedNCT01245387Results posted
- ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)CompletedNCT01213082Phase 1/2Results posted
- 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01175395Phase 1/2Results posted
- Evaluation of AL-78898A in Exudative Age-Related Macular DegenerationCompletedNCT01157065Phase 2Results posted
- Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)CompletedNCT01148511Phase 4Results posted
- Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular DegenerationCompletedNCT01134055Phase 2Results posted
- Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular DegenerationTerminatedNCT01122511Phase 2Results posted
- A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study)CompletedNCT01115556Phase 1/2Results posted
- Complement Factor H Haplotypes and Smoking in Age-related Macular DegenerationCompletedNCT01115231Results posted
- HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome DeviceCompletedNCT01103505Not applicableResults posted
- A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular DegenerationCompletedNCT01089517Phase 2Results posted
- Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular DegenerationTerminatedNCT01086761Phase 1Results posted
- Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular DegenerationCompletedNCT01027468Not applicableResults posted
- A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)TerminatedNCT01025232Phase 1/2Results posted
- Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMDTerminatedNCT01021956Phase 2Results posted
- INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMDCompletedNCT01016873Phase 2Results posted
- Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)CompletedNCT01006538Phase 4Results posted
- Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic AtrophyCompletedNCT01003691Phase 1Results posted
- Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)CompletedNCT00964795Phase 3Results posted
- Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)CompletedNCT00935883Phase 2Results posted
- Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD)CompletedNCT00931489Phase 2Results posted
- Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular AdhesionCompletedNCT00913744Phase 2Results posted
- Lucentis in Advanced Macular DegenerationCompletedNCT00896779Phase 2Results posted
- A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)CompletedNCT00891735Phase 3Results posted
- Geographic Atrophy Treatment EvaluationTerminatedNCT00890097Phase 3Results posted
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular DegenerationCompletedNCT00877032Phase 1Results posted
- Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.CompletedNCT00858208Results posted
- The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular DegenerationTerminatedNCT00857259Phase 2Results posted
- Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical PracticeCompletedNCT00787319Results posted
- S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000CompletedNCT00784225Phase 3Results posted
- Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)CompletedNCT00775411Phase 2Results posted
- Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal InjectionCompletedNCT00769392Not applicableResults posted
- Low Vision Depression Prevention Trial for Age Related Macular DegenerationCompletedNCT00769015Phase 3Results posted
- Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMDCompletedNCT00766649Phase 1/2Results posted
- Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular DegenerationCompletedNCT00764738Phase 2/3Results posted
- A Multi-Center Study of Reading Rehabilitation in Macular DiseaseCompletedNCT00746668Not applicableResults posted
- Macugen Observational StudyTerminatedNCT00735943Results posted
- An Extension to Study MD7108240CompletedNCT00733304Phase 2Results posted
- Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)CompletedNCT00729846Phase 2Results posted
- Fluocinolone Acetonide Intravitreal Inserts in Geographic AtrophyTerminatedNCT00695318Phase 2Results posted
- Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)CompletedNCT00658619Phase 2Results posted
- Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)CompletedNCT00637377Phase 3Results posted
- Alprostadil in Maculopathy Study (AIMS)TerminatedNCT00619229Phase 3Results posted
- To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMDCompletedNCT00612456Phase 2Results posted
- The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) PilotCompletedNCT00605423Phase 2Results posted
- Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin TrialCompletedNCT00593450Phase 3Results posted
- Improving Function in Age-Related Macular DegenerationCompletedNCT00572039Phase 3Results posted
- The Zeaxanthin and Visual Function StudyCompletedNCT00564902Not applicableResults posted
- A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.CompletedNCT00549055Results posted
- Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular DegenerationCompletedNCT00539734Not applicableResults posted
- Ranibizumab and Reduced Fluence PDT for AMDCompletedNCT00527475Phase 2Results posted
- Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMDCompletedNCT00527423Phase 2Results posted
- Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular DegenerationCompletedNCT00517010Early Phase 1Results posted
- Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)CompletedNCT00511706Phase 2Results posted
- Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)CompletedNCT00509795Phase 3Results posted
- Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMDTerminatedNCT00499590Phase 3Results posted
- Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)CompletedNCT00492284Phase 2Results posted
- Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular DegenerationCompletedNCT00473642Phase 4Results posted
- Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular DegenerationCompletedNCT00460408Results posted
- A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular DegenerationCompletedNCT00447954Phase 2Results posted
- Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMDCompletedNCT00446654Phase 1Results posted
- Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal NeovascularizationCompletedNCT00436553Phase 3Results posted
- Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)TerminatedNCT00433017Phase 2/3Results posted
- Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular DegenerationTerminatedNCT00423189Phase 4Results posted
- Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)TerminatedNCT00414206Phase 2Results posted
- A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular DegenerationTerminatedNCT00395057Phase 2Results posted
- An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVOCompletedNCT00379795Not applicableResults posted
- Age-Related Eye Disease Study 2 (AREDS2)CompletedNCT00345176Phase 3Results posted
- SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular DegenerationCompletedNCT00331864Phase 3Results posted
- An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMDTerminatedNCT00327470Phase 4Results posted
- Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration LesionsCompletedNCT00324116Phase 4Results posted
- Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)CompletedNCT00320788Phase 2Results posted
- OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular DegenerationCompletedNCT00306488Phase 2Results posted
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
- Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT00284089Phase 1/2Results posted
- Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT00275821Phase 3Results posted
- A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal PegaptanibCompletedNCT00242580Phase 3Results posted
- Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular DegenerationCompletedNCT00239928Phase 2Results posted
- Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular DegenerationCompletedNCT00220805Phase 2Results posted
- Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard AnesthesiaCompletedNCT07779356Phase 4
- The Efficacy of Home OCT Supported Management in Patients Diagnosed With Neovascular-AMD and Undergoing a Drug Switch to FaricimabCompletedNCT07744984
- A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNVCompletedNCT07550504Phase 2
- Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal DiseasesCompletedNCT07514559
- Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic RetinopathyCompletedNCT07501052Phase 2
- A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324CompletedNCT07484074Phase 1
- Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular DegenerationCompletedNCT07428798Not applicable
- Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History CohortCompletedNCT07424235
- Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective StudyCompletedNCT07420361
- Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular DegenerationActive, not recruitingNCT07390253
- the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular DegenerationCompletedNCT07375901Not applicable
- AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and GlaucomaCompletedNCT07318428Not applicable
- Ocular Proteomics Testing In Chronic AtrophyActive, not recruitingNCT07298291Not applicable
- CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye TrackingCompletedNCT07255885
- Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular DegenerationCompletedNCT07235527